Critical role of bacterial dissemination in an infant rabbit model of bacillary dysentery.


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
23 04 2019
Historique:
received: 28 12 2018
accepted: 28 03 2019
entrez: 25 4 2019
pubmed: 25 4 2019
medline: 14 6 2019
Statut: epublish

Résumé

The bacterial pathogen Shigella flexneri causes 270 million cases of bacillary dysentery (blood in stool) worldwide every year, resulting in more than 200,000 deaths. A major challenge in combating bacillary dysentery is the lack of a small-animal model that recapitulates the symptoms observed in infected individuals, including bloody diarrhea. Here, we show that similar to humans, infant rabbits infected with S. flexneri experience severe inflammation, massive ulceration of the colonic mucosa, and bloody diarrhea. T3SS-dependent invasion of epithelial cells is necessary and sufficient for mediating immune cell infiltration and vascular lesions. However, massive ulceration of the colonic mucosa, bloody diarrhea, and dramatic weight loss are strictly contingent on the ability of the bacteria to spread from cell to cell. The infant rabbit model features bacterial dissemination as a critical determinant of S. flexneri pathogenesis and provides a unique small-animal model for research and development of therapeutic interventions.

Identifiants

pubmed: 31015451
doi: 10.1038/s41467-019-09808-4
pii: 10.1038/s41467-019-09808-4
pmc: PMC6478941
doi:

Substances chimiques

Type III Secretion Systems 0

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

1826

Subventions

Organisme : NIDDK NIH HHS
ID : P30 DK058404
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI073904
Pays : United States

Références

PLoS One. 2014 Nov 18;9(11):e112738
pubmed: 25405985
J Infect Public Health. 2018 Jul - Aug;11(4):451-454
pubmed: 29066021
Am J Pathol. 1968 Mar;52(3):503-29
pubmed: 4966811
Acta Morphol Acad Sci Hung. 1962;11:439-54
pubmed: 13997707
Infect Immun. 2014 Nov;82(11):4447-57
pubmed: 25114112
Acta Microbiol Acad Sci Hung. 1957;4(4):367-76
pubmed: 13508157
mBio. 2010 May 18;1(1):
pubmed: 20689747
Lancet Infect Dis. 2018 Nov;18(11):1229-1240
pubmed: 30266330
Cell. 1986 Aug 15;46(4):551-5
pubmed: 3524856
Infect Immun. 1989 Mar;57(3):858-63
pubmed: 2645214
Cold Spring Harb Perspect Med. 2013 Oct 01;3(10):a016717
pubmed: 24086068
J Infect Dis. 1969 Mar;119(3):296-9
pubmed: 5780532
Proc Natl Acad Sci U S A. 1989 May;86(10):3867-71
pubmed: 2542950
N Engl J Med. 2004 Dec 2;351(23):2417-27
pubmed: 15575058
Infect Immun. 1982 Mar;35(3):852-60
pubmed: 6279518
Infect Immun. 2015 Apr;83(4):1695-704
pubmed: 25667265
Infect Immun. 2001 May;69(5):3240-7
pubmed: 11292746
J Exp Med. 1994 Oct 1;180(4):1307-19
pubmed: 7931064
Infect Immun. 2005 Mar;73(3):1466-74
pubmed: 15731044
J Immunol. 2007 Feb 15;178(4):2476-82
pubmed: 17277155
J Exp Med. 1956 Sep 1;104(3):411-8
pubmed: 13357693
Infect Immun. 1985 Jul;49(1):164-71
pubmed: 2989179
J Bacteriol. 1964 Nov;88(5):1503-18
pubmed: 16562000
Gastroenterology. 1986 Mar;90(3):654-60
pubmed: 3510937
Front Cell Infect Microbiol. 2016 Mar 11;6:29
pubmed: 27014639
Vaccine. 1991 Jun;9(6):416-22
pubmed: 1887672
Infect Immun. 1995 Nov;63(11):4350-7
pubmed: 7591070
Infect Immun. 1999 Mar;67(3):1471-80
pubmed: 10024597
J Infect Dis. 2014 Jan 15;209(2):203-15
pubmed: 23904297
Rev Infect Dis. 1991 Mar-Apr;13 Suppl 4:S314-8
pubmed: 2047656
J Cell Sci. 1999 Jun;112 ( Pt 11):1697-708
pubmed: 10318762
Cell Microbiol. 2002 Apr;4(4):223-33
pubmed: 11952639
Infect Immun. 1991 Oct;59(10):3463-71
pubmed: 1910001
J Clin Invest. 1995 Aug;96(2):884-92
pubmed: 7635983
J Cell Biol. 1999 Sep 20;146(6):1319-32
pubmed: 10491394

Auteurs

Lauren K Yum (LK)

Department of Microbiology, Immunology, and Cancer Biology, University of Virginia, Charlottesville, VA, USA.

Mariana X Byndloss (MX)

Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, TN, USA.

Sanford H Feldman (SH)

Center for Comparative Medicine, University of Virginia, Charlottesville, VA, USA.

Hervé Agaisse (H)

Department of Microbiology, Immunology, and Cancer Biology, University of Virginia, Charlottesville, VA, USA. hfa5y@virginia.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH